Clinical Trial Update: A Study of LY3023414 in Japanese Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY3023414 in Japanese participants with advanced cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LY3023414 (samotolisib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasm | Phase 1 | Status: COMPLETED